ABSTRACT. Background. Patients with sickle cell disease (SCD) often present with abdominal pain, usually attributable to vasoocclusion. Experience at a single institution suggested that appendicitis was a rare cause of abdominal symptoms in this population.
P ain caused by microvascular occlusion is among the most common clinical expressions of sickle cell disease (SCD). 1 Abdominal pain often represents a substantial diagnostic challenge in this population of patients. Although most often attributable to vasoocclusion, symptoms and signs may mimic acute surgical processes, particularly appendicitis. 2 In such circumstances, patients may undergo surgical exploration, often yielding no evidence of gross or microscopic pathology.
Anecdotal observations made by the senior pediatric surgeons at Rainbow Babies and Children's Hospital over several decades suggest that acute appendicitis (AA) is a rare event in children and adolescents with SCD. These observations prompted us to review our single-institution experience, as well as to perform a retrospective review of data accumulated from a large multicenter study of the natural history of SCD (Cooperative Study of Sickle Cell Disease, Phase I). 3 We hypothesized that the incidence of AA is significantly lower in patients with SCD than in the general population.
METHODS

Observations at Rainbow Babies and Children's Hospital
We retrospectively reviewed a 17-year experience at our institution, during which 12 patients were identified with a hospital discharge diagnosis of SCD and appendectomy. This period included an estimated 3500 patient-years. Among the 12 patients identified, the majority had incidental appendectomies at the time of other abdominal operative procedures. Only 2 patients had pathologic evidence of AA (approximate incidence of 5.7 cases per 10 000 patient-years). Histologic findings in all other appendices studied were normal. The 2 patients with documented AA involved a 16-year old male with mild SCD, and a 17-year old female receiving chronic transfusion therapy because of cerebral vascular disease.
Cooperative Study of Sickle Cell Disease Data
This dataset included 3765 patients between birth and 82 years of age, followed at 23 clinical centers between 1978 and 1988. Mean length of follow-up was 5.3 years (Ϯ 2.0 years), representing 19 886 patient-years. 4 Nine nonincidental appendectomies were performed among this group (nonincidental appendectomies were defined as primary operative procedures performed in cases of suspected AA). Unfortunately, in a majority of cases, pathologic data was unavailable for review; hence, for the purposes of this study, all cases were considered to represent AA, although it is likely that some appendices would have been pathologically normal. The incidence of appendicitis in this population is, therefore, Յ4.5 cases per 10 000 patient-years.
Appendicitis in the General Population
The 5, 6 This survey provides data on a representative sample of discharge diagnoses recorded in all short-stay, nonfederal hospitals in the United States. Data are weighted to derive national estimates of disease incidence. Among individuals 0 to 44 year of age (a range that closely approximates the SCD population database), the incidence of appendicitis was ϳ16 cases per 10 000 patient-years.
5,6
Statistical Analysis
Comparison of the incidence of AA in the SCD population with that of the general population using the paired t test yielded a highly statistically significant difference (P Ͻ .001). The likelihood of developing AA in patients with SCD was less than one third of that of the population at large.
DISCUSSION
Review of available data supports the hypothesis that the occurrence of AA is substantially lower in patients with SCD than in the general population.
We were able to demonstrate this difference with a high degree of statistical significance.
The biologic basis for this observation is unknown and deserves additional study. Possible considerations include alterations in the immune/inflammatory response in patients with SCD, a decrease in lymphoid tissue proliferation in the gastrointestinal tract leading to a lower likelihood of obstruction of appendiceal lumen, and/or an effect of prophylactic antibiotic therapy on gastrointestinal tract flora.
It has been suggested that the incidence of AA is lower in the nonwhite population, although precise data are not available. Addiss and coworkers 7 estimate that whites are ϳ1.5 times more likely to develop AA than nonwhites. However, this racial difference does not appear to account for our findings.
Our observations have considerable implications in the approach to the patient with SCD and acute abdominal pain. In the absence of florid and clear evidence of potential surgical pathology, a cautious, expectant approach seems warranted. Conservative treatment, including effective pain management, hydration, and other supportive measures, appears warranted in the majority of patients before contemplating surgical intervention. Patients with SCD and intraabdominal vasoocclusion often manifests signs suggesting surgical disease, ie, abdominal wall muscle rigidity and distention. 8 The potential for overinterpretation of these findings in the SCD population exists, particularly among physicians and surgeons with limited experience in the treatment of children and adults with hemoglobinopathy. Although relatively unusual, AA does occur in patients with SCD; hence, progressive abdominal findings during the period of observation warrants consideration of AA or other surgical complications.
In summary, our observations and analysis of available data demonstrate that AA is far less common in patients with SCD than in the population at large. The biologic basis of our findings remains unknown.
